Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.
Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.
复制标题
DOI:
10.1186/1476-4598-7-46
复制
发表时间:
2008-05-28
期刊:
影响因子:
37.3
通讯作者:
Gaur RK
中科院分区:
文献类型:
--
作者:
Gaur S;Shively JE;Yen Y;Gaur RK
Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), a cell adhesion molecule expressed in a variety of cell types is a putative tumor suppressor gene. Alternative splicing of CEACAM1 generates 11 different splice variants, which include 1–4 ectodomains with either short or long cytoplasmic domain generated by the exclusion (CEACAM1-S) or inclusion (CEACAM1-L) of exon 7. Studies in rodents indicate that optimal ratios of CEACAM1 splice variants are required to inhibit colonic tumor cell growth. We show that CEACAM1 is expressed in a tissue specific manner with significant differences in the ratios of its short (CEACAM1-S) and long (CEACAM1-L) cytoplasmic domain splice variants. Importantly, we find dramatic differences between the ratios of S:L isoforms in normal breast tissues versus breast cancer specimens, suggesting that altered splicing of CEACAM1 may play an important role in tumorogenesis. Furthermore, we have identified two regulatory cis-acting elements required for the alternative splicing of CEACAM1. Replacement of these regulatory elements by human β-globin exon sequences resulted in exon 7-skipped mRNA as the predominant product. Interestingly, while insertion of exon 7 in a β-globin reporter gene resulted in its skipping, exon 7 along with the flanking intron sequences recapitulated the alternative splicing of CEACAM1. Our results indicate that a network of regulatory elements control the alternative splicing of CEACAM1. These findings may have important implications in therapeutic modalities of CEACAM1 linked human diseases.
登录
查看更多内容
影响因子:
56.9
作者:
Cheng, J;Kapranov, P;Gingeras, TR
通讯作者:
Gingeras, TR
影响因子:
4.5
作者:
Kim, DS;Gusti, V;Gaur, RK
通讯作者:
Gaur, RK
DOI:
10.1084/jem.20030437
发表时间:
2004-02-16
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Iijima H;Neurath MF;Nagaishi T;Glickman JN;Nieuwenhuis EE;Nakajima A;Chen D;Fuss IJ;Utku N;Lewicki DN;Becker C;Gallagher TM;Holmes KV;Blumberg RS
通讯作者:
Blumberg RS
影响因子:
4.4
作者:
Chen, DH;Iijima, H;Blumberg, RS
通讯作者:
Blumberg, RS
影响因子:
4.8
作者:
Kirshner, J;Schumann, D;Shively, JE
通讯作者:
Shively, JE